JP5823486B2 - 放射線および熱の複合損傷の治療方法 - Google Patents

放射線および熱の複合損傷の治療方法 Download PDF

Info

Publication number
JP5823486B2
JP5823486B2 JP2013501540A JP2013501540A JP5823486B2 JP 5823486 B2 JP5823486 B2 JP 5823486B2 JP 2013501540 A JP2013501540 A JP 2013501540A JP 2013501540 A JP2013501540 A JP 2013501540A JP 5823486 B2 JP5823486 B2 JP 5823486B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
ionizing radiation
composition according
patient
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013501540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013523659A5 (enExample
JP2013523659A (ja
Inventor
ロジャース、キャスリーン
ディゼレガ、ギア
Original Assignee
ユニバーシティー オブ サザン カリフォルニア
ユニバーシティー オブ サザン カリフォルニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティー オブ サザン カリフォルニア, ユニバーシティー オブ サザン カリフォルニア filed Critical ユニバーシティー オブ サザン カリフォルニア
Publication of JP2013523659A publication Critical patent/JP2013523659A/ja
Publication of JP2013523659A5 publication Critical patent/JP2013523659A5/ja
Application granted granted Critical
Publication of JP5823486B2 publication Critical patent/JP5823486B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Radiation-Therapy Devices (AREA)
JP2013501540A 2010-03-26 2011-03-28 放射線および熱の複合損傷の治療方法 Expired - Fee Related JP5823486B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31789710P 2010-03-26 2010-03-26
US61/317,897 2010-03-26
PCT/US2011/030142 WO2011120032A1 (en) 2010-03-26 2011-03-28 Methods for treating combined radiation and thermal injury

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015199382A Division JP2016026189A (ja) 2010-03-26 2015-10-07 放射線および熱の複合損傷の治療方法

Publications (3)

Publication Number Publication Date
JP2013523659A JP2013523659A (ja) 2013-06-17
JP2013523659A5 JP2013523659A5 (enExample) 2014-05-15
JP5823486B2 true JP5823486B2 (ja) 2015-11-25

Family

ID=43903906

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013501540A Expired - Fee Related JP5823486B2 (ja) 2010-03-26 2011-03-28 放射線および熱の複合損傷の治療方法
JP2015199382A Withdrawn JP2016026189A (ja) 2010-03-26 2015-10-07 放射線および熱の複合損傷の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015199382A Withdrawn JP2016026189A (ja) 2010-03-26 2015-10-07 放射線および熱の複合損傷の治療方法

Country Status (9)

Country Link
US (1) US9272013B2 (enExample)
EP (1) EP2552469B1 (enExample)
JP (2) JP5823486B2 (enExample)
KR (1) KR20130066598A (enExample)
CN (1) CN102905719B (enExample)
EA (1) EA022388B1 (enExample)
MX (1) MX2012011036A (enExample)
SG (2) SG184247A1 (enExample)
WO (1) WO2011120032A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012106427A2 (en) * 2011-02-02 2012-08-09 University Of Southern California Methods for treating diabetic foot ulcers
WO2013172956A1 (en) * 2012-05-14 2013-11-21 University Of Southern California Methods for limiting development of a skin wound
WO2014021942A1 (en) * 2012-08-01 2014-02-06 University Of Southern California Methods for limiting development of neurodegeneration
US9623084B2 (en) 2013-03-15 2017-04-18 University Of Southern California Methods for treating multiple sclerosis
ES2834430T3 (es) 2013-03-15 2021-06-17 Univ Southern California Procedimientos, compuestos y composiciones para el tratamiento de enfermedades relacionadas con la angiotensina
RU2647369C2 (ru) * 2016-08-16 2018-03-15 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ лечения острой ожоговой токсемии организма и способ получения противоожоговой сыворотки реконвалесцентов для лечения ожоговой токсемии организма

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110895A (en) * 1996-12-16 2000-08-29 University Of Southern California Method of promoting healing in skin grafts
AU6650098A (en) * 1997-02-04 1998-08-25 University Of Southern California Method for accelerating healing of thermal injuries
ATE268782T1 (de) * 1997-12-12 2004-06-15 Univ Southern California Zusammensetzungen zur wundheilung
US7173011B2 (en) * 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
EP1061937A1 (en) 1998-03-10 2000-12-27 University Of Southern California Improved radiation therapy methods
EP1165099B1 (en) * 1999-03-23 2006-08-09 University Of Southern California Angiotensin ii and analogs thereof for limiting scar and adhesion formation
CN1706502A (zh) * 2005-05-25 2005-12-14 中国药科大学 一种抗高血压核酸疫苗及其制备方法
US20070293458A1 (en) * 2006-06-16 2007-12-20 Ip-6 Research Inc. Prevention of nuclear, solar, and other radiation-induced tissue damage

Also Published As

Publication number Publication date
EA201201338A1 (ru) 2013-03-29
EP2552469A1 (en) 2013-02-06
JP2016026189A (ja) 2016-02-12
SG184247A1 (en) 2012-10-30
EP2552469B1 (en) 2014-09-03
WO2011120032A1 (en) 2011-09-29
SG10201502348VA (en) 2015-05-28
EA022388B1 (ru) 2015-12-30
JP2013523659A (ja) 2013-06-17
MX2012011036A (es) 2013-03-18
US9272013B2 (en) 2016-03-01
CN102905719B (zh) 2015-04-22
CN102905719A (zh) 2013-01-30
US20130123190A1 (en) 2013-05-16
KR20130066598A (ko) 2013-06-20

Similar Documents

Publication Publication Date Title
JP2016026189A (ja) 放射線および熱の複合損傷の治療方法
ES2399276T3 (es) Uso de péptidos para el control de lesiones por radiación
Guillen et al. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis
Hanson et al. Comparison of in vivo murine intestinal radiation protection by E-prostaglandins
US7179456B2 (en) Use of parvovirus for brain tumor therapy
CN108883134A (zh) 活化干细胞和用于感染伤口的全身治疗方法
Jellish et al. Intrathecal magnesium sulfate administration at the time of experimental ischemia improves neurological functioning by reducing acute and delayed loss of motor neurons in the spinal cord
Guttman et al. Progressive intercapillary glomerulosclerosis in aging and irradiated beagles
JP2013523659A5 (enExample)
JPH10502371A (ja) リンホトキシンを用いる癌処置法
ES2661173T3 (es) Combinación de solución de aminoácidos y un derivado de gelatina para inhibir la absorción renal
JP6150374B2 (ja) 放射線被ばく治療剤及び放射線被ばく治療方法
JP2009529037A (ja) 放射線障害の制御の為にペプチドを使用する方法
Jung et al. Effect of the radioprotector WR2721 on irradiation-induced injury to ciliated cells of eustachian tube
US20080318869A1 (en) Method to Promote Wound Healing
CN100501400C (zh) 使用α胸腺素防护辐射损伤的方法
RU2568364C1 (ru) Способ для кастрации самцов сельскохозяйственных животных
CN111420070B (zh) Tigar基因或蛋白在制备放射性胃肠综合征救治药物中的应用
AU2021107007A4 (en) Use of walnut extract in preparing medicine for treating burn wounds
NOOJIN et al. Hyaluronidase action in normal and in roentgen-irradiated rabbit skin
da Silva et al. Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease: Zootecnia
CN118021939A (zh) Bmp4蛋白或其衍生物在制备药物中的用途
JP3584349B2 (ja) 腸粘膜障害用薬剤
Kahn Irradiation and Tissue Immunity: II. Response to Injection of Staphylococci in X-Irradiated Skin Areas of Rabbits
Straube et al. Effect of local X-irradiation on growth capacity of mouse kidney

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140326

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150608

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150908

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151007

R150 Certificate of patent or registration of utility model

Ref document number: 5823486

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees